+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Energy-Based Therapeutics Market by Product Type, Clinical Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924843
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Energy-Based Therapeutics Market grew from USD 6.80 billion in 2023 to USD 7.28 billion in 2024. It is expected to continue growing at a CAGR of 7.36%, reaching USD 11.19 billion by 2030.

Energy-based therapeutics encompass a range of medical treatments that utilize energy forms such as electricity, ultrasound, radiation, and thermal energy to treat various medical conditions. The scope of these therapeutics is broad, encompassing dermatological, oncological, cardiovascular, and ophthalmological applications, among others. This need arises from the increasing demand for non-invasive or minimally invasive treatments that offer precise targeting of diseased tissues, potentially reducing recovery time and side effects. The application scope is expanding with technological advancements in laser therapy, radiofrequency ablation, and phototherapy, enabling targeted treatment approaches and enhancing patient outcomes. Key end-users include hospitals, specialty clinics, research institutions, and homecare settings.

In terms of market dynamics, the growth is primarily driven by the rising prevalence of chronic diseases, advancements in device technology, and increased patient awareness. The growing acceptance of cosmetic energy-based procedures further fuels market expansion. However, high equipment costs, regulatory challenges, and a shortage of trained personnel pose significant hurdles. Additionally, the intricate regulatory processes can delay product launches, impacting market dynamics. Despite these limitations, opportunities abound in developing portable and cost-effective devices tailored for emerging markets. To capitalize on these opportunities, companies should focus on partnerships for technological innovation and cater to growing consumer demand for at-home care solutions.

Innovation should target improving energy delivery systems for better efficacy and safety. Research can focus on developing hybrid devices that combine multiple energy forms for comprehensive treatment solutions. Companies can gain competitive advantages by investing in comprehensive training programs to address the personnel shortage issue. The nature of the energy-based therapeutics market is dynamic, often driven by technological trends and consumer demands. Continuous innovation, strategic collaborations, and navigating regulatory pathways effectively are crucial for sustaining growth and capturing emerging opportunities in this evolving landscape.

Understanding Market Dynamics in the Energy-Based Therapeutics Market

The Energy-Based Therapeutics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
    • The surge in popularity of microwave ablation systems over conventional surgeries and treatment
  • Market Restraints
    • Increasing frequency of product recalls
  • Market Opportunities
    • Technological innovations and developments in energy-based therapeutics
    • Government initiatives and favorable reimbursement policies for energy-based therapeutics
  • Market Challenges
    • The dearth of awareness and skilled manpower and therapeutic challenges

Exploring Porter’s Five Forces for the Energy-Based Therapeutics Market

Porter’s Five Forces framework further strengthens the insights of the Energy-Based Therapeutics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Energy-Based Therapeutics Market

External macro-environmental factors deeply influence the performance of the Energy-Based Therapeutics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Energy-Based Therapeutics Market

The Energy-Based Therapeutics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Energy-Based Therapeutics Market

The Energy-Based Therapeutics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Energy-Based Therapeutics Market

The Energy-Based Therapeutics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Energy-Based Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC, Alna-Medicalsystem AG, AngioDynamics, AtriCure, Inc., BIOLASE, Inc., Biolitec AG, Boston Scientific Corporation, Bovie Medical Corporation, Candela Corporation by Syneron Medical Ltd., Cutera, Inc., Cynosure Inc., Dornier MedTech GmbH, EDAP TMS S.A., Ellex Medical Lasers, InSightec Ltd., IRIDEX Corporation, Johnson and Johnson Vision Care Inc, LightMed Corporation, Lumenis Ltd., Medtronic plc, NIDEk CO. LTD, Optos plc, PhotoMedex, Inc., Symmetry Surgical Inc., and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Energy-Based Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Cryotherapy
    • Hydro-Mechanical
    • Microwave
    • Radiofrequency
    • Thermal & Ultrasound
  • Clinical Application
    • Aesthetic
    • Surgical & Ophthalmic
  • End-User
    • Clinics
    • Hospital
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
5.1.1.2. The surge in popularity of microwave ablation systems over conventional surgeries and treatment
5.1.2. Restraints
5.1.2.1. Increasing frequency of product recalls
5.1.3. Opportunities
5.1.3.1. Technological innovations and developments in energy-based therapeutics
5.1.3.2. Government initiatives and favorable reimbursement policies for energy-based therapeutics
5.1.4. Challenges
5.1.4.1. The dearth of awareness and skilled manpower and therapeutic challenges
5.2. Market Segmentation Analysis
5.2.1. Product Type: Growing use of thermal & ultrasound energy-based therapeutics to treat deep-seated lesions
5.2.2. Clinical Application: Adoption of energy-based therapeutics in aesthetic application
5.2.3. End-User: Emergence of a specialized clinic for energy-based therapeutics
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Energy-Based Therapeutics Market, by Product Type
6.1. Introduction
6.2. Cryotherapy
6.3. Hydro-Mechanical
6.4. Microwave
6.5. Radiofrequency
6.6. Thermal & Ultrasound
7. Energy-Based Therapeutics Market, by Clinical Application
7.1. Introduction
7.2. Aesthetic
7.3. Surgical & Ophthalmic
8. Energy-Based Therapeutics Market, by End-User
8.1. Introduction
8.2. Clinics
8.3. Hospital
9. Americas Energy-Based Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Energy-Based Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Energy-Based Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Baird Medical’s Microwave Ablation System Gains FDA 510(k) Clearance
12.3.2. Oculus launches IPL, Radiofrequency Therapy Devices
12.3.3. Emblation Launches Swift Microwave Therapy in the Middle East
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ENERGY-BASED THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. ENERGY-BASED THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ENERGY-BASED THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ENERGY-BASED THERAPEUTICS MARKET DYNAMICS
TABLE 7. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HYDRO-MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY MICROWAVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY THERMAL & ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY SURGICAL & OPHTHALMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Energy-Based Therapeutics market, which are profiled in this report, include:
  • Alcon Vision LLC
  • Alna-Medicalsystem AG
  • AngioDynamics
  • AtriCure, Inc.
  • BIOLASE, Inc.
  • Biolitec AG
  • Boston Scientific Corporation
  • Bovie Medical Corporation
  • Candela Corporation by Syneron Medical Ltd.
  • Cutera, Inc.
  • Cynosure Inc.
  • Dornier MedTech GmbH
  • EDAP TMS S.A.
  • Ellex Medical Lasers
  • InSightec Ltd.
  • IRIDEX Corporation
  • Johnson and Johnson Vision Care Inc
  • LightMed Corporation
  • Lumenis Ltd.
  • Medtronic plc
  • NIDEk CO. LTD
  • Optos plc
  • PhotoMedex, Inc.
  • Symmetry Surgical Inc.
  • Ziemer Ophthalmic Systems AG

Methodology

Loading
LOADING...

Table Information